Formulation methods for peptide-modified lipid nanoparticles.

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Lipid nanoparticles (LNPs) are advanced non-viral vectors for gene delivery.
• Targeting specific cells in organs outside the liver remains a significant challenge for LNP technology.

Purpose of the Study:

• To compare two methods for displaying targeting peptides on LNPs: post-conjugation targeted (PCT) and in-line targeted (ILT).
• To evaluate the efficacy of these LNP formulations for cell-specific delivery and gene transfection in extrahepatic organs.

Main Methods:

• Formulation of LNPs using PCT and ILT approaches with polyethylene glycol (PEG)-lipid conjugates displaying targeting peptides.
• Characterization of LNP physicochemical properties, including aggregation.
• Assessment of LNP binding, cellular uptake, and transfection activity in vitro and in vivo using cyclic RGD as a model ligand.
• Analysis of organ biodistribution and cell tropism following systemic administration.

Main Results:

• PCT and ILT LNPs exhibited comparable physicochemical properties, though ILT LNPs showed aggregation with larger peptides.
• In vitro studies revealed similar binding and uptake for both LNP types, but PCT LNPs demonstrated higher activity.
• In vivo studies indicated that both methods altered organ biodistribution, with PCT LNPs achieving superior transfection efficiency.
• PCT cRGD LNPs specifically targeted endothelial cells in multiple organs, enhancing transfection activity.

Conclusions:

• Post-conjugation targeting (PCT) of lipid nanoparticles (LNPs) results in superior formulations for active peptide targeting compared to in-line targeted (ILT) methods.
• Despite requiring additional processing steps, PCT LNPs offer enhanced gene delivery and cell-specific transfection in extrahepatic tissues.
• This study highlights the importance of formulation strategy in optimizing LNP-based gene therapy for targeted delivery.